the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)

NCT03264794 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Gefitinib Tab （CTTQ），First medication；Gefitinib Tab （CTTQ），From the 8th day of trial
DRUG: Gefitinib tablets (Yi Ruisha），First medication
DRUG: Gefitinib Tab 250 MG（CTTQ），From the 8th day of trial.

Sponsor

Jiangsu Famous Medical Technology Co., Ltd.